Inappropriate wetting and voiding habits are common in children, constituting 20% to 25% of new patients seen in the pediatric urology office setting.
Dr. Laurence Baskin discusses robotic pediatric urological surgery at UCSF
"Robotic surgery has some major advantages. One that rises to the top is that your magnification is anywhere from 10x-15x higher," according to Laurence S. Baskin, MD.
Speaking of Urology: Dr. Finkelstein discusses telemedicine for pediatric post-op visits
In this episode, Julia Beth Finkelstein, MD, MPH, CPPS, discusses what she and her co-authors learned from a recent study evaluating the use of telemedicine for pediatric post-op visits.
Nedosiran explored in primary hyperoxaluria type 3
The RNAi drug nedosiran is a once-monthly subcutaneous injection under investigation for all 3 types of primary hyperoxaluria.
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria
FDA new drug application filing expected by the end of 2021.
Medical professionals to discuss circumcision on Twitter
Join Urology Times and Contemporary Pediatrics for a discussion about controversies over circumcision and its implications.
FDA approves androgen inhibitor for metastatic PCa
The FDA recently approved the oral androgen receptor inhibitor enzalutamide (Xtandi) for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel (Taxotere).
2 Commerce Drive Cranbury, NJ 08512